HTS Settles ClinPhone License Dispute

Healthcare Technology Systems, Inc., (HTS) announced today that it has settled its dispute with ClinPhone PLC. The dispute arose over ClinPhone's exclusive license to HTS technology.

Under the terms of the settlement, HTS agreed to repay ClinPhone an undisclosed sum in terminating the exclusive license and entering into a non-exclusive license. This fundamental change will allow HTS to provide its products and services to customers directly, or with other partners. A new formula for royalty payments has been agreed, and HTS physicians will provide limited support to ClinPhone upon request.

Healthcare Technology Systems, led by John H. Greist, MD, James W. Jefferson, MD, David J. Katzelnick, MD, and Chris Snyder, MBA, is the world leader in creating, developing and implementing clinical IVR systems. HTS currently offers more than 50 clinical electronic patient-self assessments. In August 2004, FDA indicated acceptance of patient self-report assessments, including HTS' IVR Hamilton Depression Rating Scale (HAM-D), as primary outcome measures in depression studies. HTS also conducts research in a variety of areas, including creation and validation of assessments, development and validation of computerized therapeutic interventions, disease management programs, health services research, and protocol analysis.